Literature DB >> 19285514

Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.

Qi-Shi Du1, Ri-Bo Huang, Cheng-Hua Wang, Xiao-Ming Li, Kuo-Chen Chou.   

Abstract

Understanding the mechanism of the M2 proton channel of influenza A is crucially important to both basic research and drug discovery. Recently, the structure was determined independently by high-resolution NMR and X-ray crystallography. However, the two studies lead to completely different drug-binding mechanisms: the X-ray structure shows the drug blocking the pore from inside; whereas the NMR structure shows the drug inhibiting the channel from outside by an allosteric mechanism. Which one of the two is correct? To address this problem, we conducted an in-depth computational analysis. The conclusions drawn from various aspects, such as energetics, the channel-gating dynamic process, the pK(a) shift and its impact on the channel, and the consistency with the previous functional studies, among others, are all in favour to the allosteric mechanism revealed by the NMR structure. The findings reported here may stimulate and encourage new strategies for developing effective drugs against influenza A, particularly in dealing with the drug-resistant problems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285514     DOI: 10.1016/j.jtbi.2009.03.003

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  21 in total

Review 1.  Flu channel drug resistance: a tale of two sites.

Authors:  Rafal M Pielak; James J Chou
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

2.  An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition.

Authors:  Yuki Ohigashi; Chunlong Ma; Xianghong Jing; Victoria Balannick; Lawrence H Pinto; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

3.  Docking and molecular dynamics study on the inhibitory activity of N, N-disubstituted-trifluoro-3-amino-2-propanols-based inhibitors of cholesteryl ester transfer protein.

Authors:  Bo-Liang Dong; Qing-Hua Liao; Jing Wei
Journal:  J Mol Model       Date:  2010-11-06       Impact factor: 1.810

4.  Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel.

Authors:  Rafal M Pielak; James J Chou
Journal:  Biochem Biophys Res Commun       Date:  2010-09-15       Impact factor: 3.575

5.  Computer-aided de novo ligand design and docking/molecular dynamics study of vitamin D receptor agonists.

Authors:  Xiu-Long Shen; Midori Takimoto-Kamimura; Jing Wei; Qing-Zhi Gao
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

6.  Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.

Authors:  Qi-Shi Du; Ri-Bo Huang; Shu-Qing Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2010-02-23       Impact factor: 3.240

7.  Analysis and prediction of the metabolic stability of proteins based on their sequential features, subcellular locations and interaction networks.

Authors:  Tao Huang; Xiao-He Shi; Ping Wang; Zhisong He; Kai-Yan Feng; Lele Hu; Xiangyin Kong; Yi-Xue Li; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

8.  Molecular level understanding of resistance to nalidixic acid in Salmonella enteric serovar typhimurium associates with the S83F sequence type.

Authors:  B Preethi; K Ramanathan
Journal:  Eur Biophys J       Date:  2015-09-02       Impact factor: 1.733

9.  Identification of ligand binding site on RXRγ using molecular docking and dynamics methods.

Authors:  Peng Zhao; Qing-hua Liao; Cheng-Feng Ren; Jing Wei
Journal:  J Mol Model       Date:  2010-08-26       Impact factor: 1.810

10.  Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs.

Authors:  Jing-Fang Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.